The articles listed on this page are from a variety of sources. 
1. The staff of DBS-STN often attends conferences or educational opportunities both nationally and internationally, and a brief understandable write-up of the information presented at the event will be provided for our readers to review. 
2. DBS-STN staff also identifies or writes various articles related to topics that are thought to be of interest for the reader of www.DBS-STN.org. 

Browse by Topic:
Search:

Civitas Announces Positive Results from Phase II Inhaled Levodopa Trial


Civitas Therapeutics announced that its inhaled formulation of levodopa (L-dopa) for the treatment of "off episodes" associated with Parkinson's disease met its primary clinical endpoint in a Phase II trial. Read more…



Article Archive

back